STAT+: Pharmalittle: Sacklers and states agree to $6 billion opioid settlement; Biogen layoffs get under way
And so, another working week will soon draw to a close. Not a moment too…
Category: Pharmalot
STAT+: Washington state moves closer to creating the next prescription drug affordability board
In a closely watched development, House lawmakers in Washington state passed a bill to create…
Sacklers agree to $6 billion Purdue bankruptcy settlement over opioid crisis
The Sackler family members who own Purdue Pharma have agreed to a $6 billion settlement…
STAT+: Pharmalittle: U.S. will share some coronavirus technologies with WHO; Civica Rx tries unconventional bid to make cheap insulin
Top of the morning to you, and a fine one it is. A shiny sun…
STAT+: Civica Rx has an ambitious plan to make low-cost insulin for all Americans. But can it work?
In an unconventional bid to widen access to insulin for Americans, a nonprofit announced plans…
STAT+: Nevada joins a little-known, ambitious state consortium dedicated to better drug prices
After months of talks, the state of Nevada has joined a consortium formed by Oregon…
STAT+: Pharmalittle: U.S. Supreme Court examines when misprescribing is criminal; Biden calls for capping insulin at $35
Top of the morning to you. Another busy day is unfolding here on the Pharmalot…
STAT+: Tennessee judge sanctions Endo for ‘coordinated strategy’ to withhold documents in opioid case
Endo International (ENDP) was sanctioned by a Tennessee state court judge for using a “coordinated…
STAT+: Pharmalittle: Broad Institute wins legal battle over CRISPR patents; Pfizer’s C. diff vaccine fails in study
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
.jpg)
STAT+: Oregon withdraws a waiver request to run a closed Medicaid formulary
In response to a raft of concerns, Oregon has withdrawn a request made to federal…
STAT+: Ants, spiders, and mold: Why a big compounding pharmacy recently recalled all its products
Last December, a little known compounding pharmacy recalled all of its products due to “process…
STAT+: Pharmalittle: FTC’s top economist quits amid PBM-study spat; FDA clinical holds have become more common
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: J&J and wholesalers finalize opioid settlement; more than half of U.S. abortions involved a pill
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Johnson & Johnson, three pharma wholesalers finalize $26 billion opioid crisis settlement
Johnson & Johnson (JNJ) and three major pharmaceutical wholesalers have finalized nationwide settlements over their…
STAT+: NIH official accused of ‘bias’ against using a controversial law to address high drug prices
The campaign to use so-called march-in rights to widen access to a cancer drug is…
STAT+: Political pressure in the U.K. prompted more universities to report clinical trial results
Sometimes, sabre rattling works. Three years ago, a U.K. Parliamentary committee chair warned dozens of…
STAT+: Judge bars Shkreli from running another public company, fines him $1.4 million
A U.S. District Court judge has granted a request from the U.S. Securities and Exchange…
STAT+: Pharmalittle: Drugmakers push back against Medicare on Alzheimer’s drug; South Africa says Merck Covid pill isn’t cost-effective
Good morning, everyone, and how are you today? Gray skies are hovering over the Pharmalot…
STAT+: Chilean health ministry is urged to issue a compulsory license for the Pfizer Covid pill
In the latest bid to expand access to the Pfizer (PFE) Covid-19 pill, a nonprofit…
STAT+: Institutional investors urge pharma boards to tie executive compensation to global Covid vaccine equity
More than 65 institutional investors are urging the directors of companies making Covid-19 vaccines to…
STAT+: Pharmalittle: More top hospitals aren’t offering Biogen Alzheimer’s drug; Pfizer may lower Covid pill price in poor countries until supplies rise
Hello, everyone, and how are you today? Cloudy skies are hovering this morning over the…
STAT+: Pharmalittle: U.S. doubles order of Pfizer Covid-19 pill; court revives suit claiming drug makers funded terrorism in Iraq
Rise and shine, everyone, another busy day is on the way. Yes, indeed, the middle…
STAT+: Some drug makers quietly resumed donations to lawmakers who denied Biden’s election victory
Four major drug makers each donated tens of thousands of dollars last year to Republican…
STAT+: Pharmalittle: Pharma raises median drug prices by 4.9%, so far; Covid forces some lawmakers to ponder pharma gifts
Top of the morning to you, and a fine one it is. Clear skies and…
STAT+: Drug makers ring in the new year with 5% price hikes on hundreds of medicines
As 2022 gets under way, pharmaceutical companies have so far raised wholesale prices by a…
STAT+: HHS appeals rulings over drug discount program just as AbbVie is latest to cut discounts
A heated clash over a U.S. government drug discount program has intensified after a federal…
STAT+: Pharmalittle: New Covid-19 vaccine developers expect nothing in return; COVAX distribution falls short of goals
Good morning, everyone, and nice to see you again after a long break. For those…
.jpg)
STAT/Harris Poll: Vaccinated Americans far more likely to take Pfizer Covid-19 pill than unvaccinated people
Just before regulators authorized use of a widely publicized Covid-19 pill from Pfizer, only half…
STAT+: 3 pharma trends to watch in 2022
As 2021 winds down, the proverbial rearview mirror displays a mix of spectacular success, vexing…
STAT+: Pharmalittle: Japan panel nixes Biogen Alzheimer’s drug; Oxfam urges SEC to probe Moderna over patent dispute remarks
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT+: Oxfam wants the SEC to investigate Moderna for ‘misleading’ investors about its Covid patent dispute with NIH
Oxfam America has filed a complaint with securities regulators accusing Moderna (MRNA) of providing “misleading…
STAT+: By endorsing a first injectable for HIV prevention, FDA creates alternative to pills and a battle among drug makers
In a notable development, the first long-acting injectable shot for preventing HIV was approved by…
STAT+: Pharmalittle: Moderna says booster shot raises antibody levels to thwart Omicron; Sanofi buys yet another biotech
Rise and shine, everyone, another busy day is on the way. Although it may feel…
STAT+: University of Chicago professor charged with insider trading over a cancer drug trial
A University of Chicago associate professor who worked as a clinical trial investigator for Five…
STAT+: Pharmalittle: Biogen cuts price of Alzheimer’s drug in half and plans cost cuts; Moderna test suggests booster works against Omicron
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: AbbVie asks the U.S. International Trade Commission to investigate Alvotech’s plans for a biosimilar Humira
In its latest bid to defend its franchise product, AbbVie (ABBV) has filed a complaint…
STAT+: Facing intense criticism, Moderna pauses bitter dispute with the NIH over Covid-19 vaccine patents
Moderna (MRNA) has halted a rancorous patent dispute with the U.S. government over assigning credit…
STAT+: Pharmalittle: Judge reverses Purdue Pharma bankruptcy plan; FDA eases access restrictions on abortion pills
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Judge reverses $4.5 billion Purdue Pharma bankruptcy settlement
A federal court judge has reversed the hotly contested Purdue Pharma bankruptcy plan after deciding…
FDA lifts key restriction on abortion pill, allowing it to be obtained by mail
Amid national furor over abortion, the Food and Drug Administration permanently removed a controversial restriction…
STAT+: Biden administration seeks a legislative path for novel antibiotic drug development
Amid rising concerns over antibiotic resistance, the U.S. Department of Health and Human Services is…
STAT+: FDA rebukes Endo for ‘anticompetitive practices,’ asks FTC to investigate
In an unusual move, the U.S. Food and Drug Administration has openly suggested that a…
STAT+: Pharmalittle: Biogen to start large trial to confirm Alzheimer’s drug benefits; FDA to decide on easier access to abortion pill
Top of the morning, and a fine one, it is. The sun is trying to…
Poll: Omicron is forcing Americans to rethink some — but not all — of their holiday plans
Four out of five vaccinated Americans say they will still wear a mask inside public…
STAT+: Pharmalittle: Califf sails through hearing for top FDA job; J.P. Morgan goes virtual after big biotechs pull out
Hello, everyone, and how are you today? We are doing just fine, thank you, since…
STAT+: Pharmalittle: Pfizer Covid pill retains 89% efficacy in full study; Senate committee holds hearing on FDA commissioner
Rise and shine, folks, another busy day is on the way. We can tell, thanks…
STAT+: Feeling remote: Coalition of pharma regulators look to complement on-site inspections beyond Covid
Nearly two years after the Covid-19 pandemic prompted remote inspections of pharmaceutical production plants, an…
STAT+: Pharmalittle: Pfizer to pay $6.7 billion for Arena and a bowel disease drug; ASH brings flood of data readouts
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Generic drug makers win a court round as judge temporarily blocks California pay-to-delay law
In a victory for generic drug makers, a federal court judge temporarily blocked a controversial California…
STAT+: Pharmalittle: Fauci unconvinced Omicron-specific vaccines are needed; J&J rebuffed warnings about a diabetes drug
And so, another working week will soon draw to a close. Not a moment too…